The TRICALS consortium unifies leading ALS-experts, patient advocacy groups and ALS foundations across Europe. By working together, we can accelerate clinical drug development for ALS. Through our unique network of harmonized and trial-ready ALS centres, we serve a well-defined patient population across 14 countries. All our centres have an excellent track record in industry and investigator-initiated clinical trials, resulting in on point recruitment and high-quality research. Centralized knowledge gives a cutting-edge advantage in trial innovation and excellence.